Literature DB >> 28476325

Intolerance to roflumilast in real-life clinical practice.

Mónica Gómez-Rodríguez1, Rafael Golpe2.   

Abstract

Keywords:  Chronic obstructive pulmonary disease; Intolerance; Roflumilast

Mesh：

Substances：

Year:  2017        PMID： 28476325     DOI： 10.1016/j.ejim.2017.04.019

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN： 0953-6205            Impact factor:   4.487


× No keyword cloud information.
  3 in total

1.  Efficacy and safety profile of roflumilast in a real-world experience.

Authors:  Aykut Cilli; Halid Bal; Hakan Gunen
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

Review 2.  Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases.

Authors:  Heng Li; Jianping Zuo; Wei Tang
Journal:  Front Pharmacol       Date:  2018-10-17       Impact factor: 5.810

3.  Efficacy and safety of CHF6001, a novel inhaled PDE4 inhibitor in COPD: the PIONEER study.

Authors:  Dave Singh; Aida Emirova; Catherine Francisco; Debora Santoro; Mirco Govoni; Marie Anna Nandeuil
Journal:  Respir Res       Date:  2020-09-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.